Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1.45 INR
Change Today 0.00 / 0.00%
Volume 0.0
GRD On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

hindustan bio sciences ltd (GRD) Snapshot

Open
1.45
Previous Close
1.52
Day High
1.45
Day Low
1.45
52 Week High
08/12/15 - 2.23
52 Week Low
11/25/14 - 1.09
Market Cap
14.9M
Average Volume 10 Days
875.0
EPS TTM
-1.42
Shares Outstanding
10.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HINDUSTAN BIO SCIENCES LTD (GRD)

Related News

No related news articles were found.

hindustan bio sciences ltd (GRD) Related Businessweek News

No Related Businessweek News Found

hindustan bio sciences ltd (GRD) Details

Hindustan Bio Sciences Limited imports and markets recombinant human erythropoietin under the brand names of EPOVIN, EPOSINO, and TRANSFER & NEPHRODIL in India. The company was incorporated in 1991 and is based in Hyderabad, India.

Founded in 1991

hindustan bio sciences ltd (GRD) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hindustan bio sciences ltd (GRD) Key Developments

Hindustan Bio Sciences Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2015

Hindustan Bio Sciences Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported income from operations of INR 501.8 million, profit from operations before other income, finance costs and exceptional items of INR 33.3 million, profit from ordinary activities before tax of INR 26.1 million and net profit of INR 26.1 million or INR 0.03 per basic and diluted share compared to income from operations of INR 20.9 million, loss from operations before other income, finance costs and exceptional items of INR 933.5 million, loss from ordinary activities before tax of INR 940.4 million and net loss of INR 940.4 million or INR 0.92 per basic and diluted share reported in the same period last year.

Hindustan Bio Sciences Ltd., Board Meeting, Jul 31, 2015

Hindustan Bio Sciences Ltd., Board Meeting, Jul 31, 2015. Agenda: To consider unaudited standalone earnings results for the first quarter ended June 30, 2015.

Hindustan Bio Sciences Ltd., Board Meeting, May 30, 2015

Hindustan Bio Sciences Ltd., Board Meeting, May 30, 2015. Agenda: To consider audited results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GRD:IN 1.45 INR 0.00

GRD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GRD.
View Industry Companies
 

Industry Analysis

GRD

Industry Average

Valuation GRD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.0x
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HINDUSTAN BIO SCIENCES LTD, please visit www.hindustanbiosciences.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.